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The recently sequenced genomes of several Asper-
gillus species have revealed that these organisms
have the potential to produce a surprisingly large
range of natural products, many of which are cur-
rently unknown. We have found that A. nidulans pro-
duces emericellamide A, an antibiotic compound of
mixedoriginswithpolyketideandaminoacidbuilding
blocks. Additionally, we describe the discovery of
four previously unidentified, related compounds
that we designate emericellamide C–F. Using re-
cently developed gene targeting techniques, we
have identified the genes involved in emericellamide
biosynthesis. The emericellamide gene cluster con-
tains one polyketide synthase and one nonribosomal
peptide synthetase. From the sequences of the
genes, we are able to deduce a biosynthetic pathway
for the emericellamides. The identification of this bio-
synthetic pathway opens the door to engineering
novel analogs of this structurally complexmetabolite.
INTRODUCTION
Secondary metabolites are a rich source of medically useful
compounds. The recent sequencing of a number of fungal ge-
nomes reveals, surprisingly, that common fungi may be a rich
and underexploited source of secondary metabolites. The se-
quencing of the genomes of four species of the genus Aspergil-
lus, for example (Galagan et al., 2005; Machida et al., 2005; Nier-
man et al., 2005; Pel et al., 2007), revealed that they have many
more secondary metabolite pathways than was suspected from
decades of natural product chemistry.A. nidulans has 27 polyke-
tide synthases (PKSs) and 14 nonribosomal peptide synthetases
(NRPSs), but the products of fewer than 10 biosynthesis gene
clusters had been identified at the time the genome was
completed (Bergmann et al., 2007; Bok et al., 2006; Haas,
2003; Hoffmeister and Keller, 2007; Marquez-Fernandez et al.,Chemistry & Biology2007; Scherlach and Hertweck, 2006). Moreover, the genes of
individual secondary metabolite pathways are almost always
clustered together in the genome, which potentially facilitates
study and molecular genetic manipulation (Brown et al., 1996).
The realization that common laboratory fungi are a likely
source of many more natural products has been accompanied
by important advances in the molecular genetic manipulation
of some of these fungi. One was the development of fusion poly-
merase chain reaction (PCR) techniques that have greatly facili-
tated the production of linear molecules for gene replacements,
promoter replacements, and gene tagging (Kuwayama et al.,
2002; Nayak et al., 2006; Szewczyk et al., 2006; Yang et al.,
2004; Zarrin et al., 2005). A second was the discovery that dele-
tion of KU genes, the products of which are required for nonho-
mologous end joining, greatly improves gene-targeting frequen-
cies (da Silva Ferreira et al., 2006; Krappmann et al., 2006; Nayak
et al., 2006; Ninomiya et al., 2004; Takahashi and Smithies,
1999).We have applied these approaches to natural product dis-
covery in A. nidulans and, in particular, have used them to iden-
tify and characterize the emericellamide biosynthesis pathway.
RESULTS AND DISCUSSION
With the expectation that deleting each biosynthetic genewill result
in the inability to synthesize one or more secondary metabolites in
the same biosynthetic pathway, we randomly selected six NRPS
genes, using the Broad Institute designation (http://www.broad.
mit.edu/annotation/genome/Aspergillus_group/MultiHome.html)—
that is, AN0607.3, AN1242.3, AN2545.3, AN2621.3, AN8412.3,
and AN9244.3 (see Tables S1 and S2 available online)—and
deleted each of them. One of the NRPS genes, AN8412.3, has
recently been shown to be involved in aspyridone biosynthesis
(Bergmann et al., 2007). The selective disruption of each gene
was verified by diagnostic PCR (data not shown). The results of
HPLC profiles show that only the AN2545.3 deletant exhibited
a different profile from the control, whereas the other five NRPS
deletantswere the sameas thewild-type (data not shown). These
results highlight the fact that most biosynthetic gene clusters
are cryptic, at least in common laboratory culture conditions.
Though both wild-type and the AN2545.3 deletant still produce15, 527–532, June 2008 ª2008 Elsevier Ltd All rights reserved 527
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Aspergillus Emericellamide PathwayFigure 1. LC-DAD-MS Analysis of Wild-Type A. nidulans and DAN2545 Mutant Metabolites
(A) UV trace at 254 nm.
(B) Positive ionmode: total ion current (TIC); extracted ion current (EIC) at m/z 325, sterigmatocystin [M+H]+; EIC at m/z 491, terrequinone [M+H]+; EIC at m/z 596,
emericellamides C and D [M+H]+; EIC at m/z 610, emericellamide A [M+H]+; EIC at m/z 624, emericellamides E and F [M+H]+. *A minor compound that has same
MS/MS fragmentation with emericellamide A.
(C) Chemical structures of emericellamides.sterigmatocystin (ST) and terrequinone (TQ) (Figure 1A), fivecom-
pounds with m/z = 609 (m/z = 610 [M+H]+, compound 1), m/z =
595 (m/z = 596 [M+H]+, compounds 2 and 3), and m/z = 623
(m/z = 624 [M+H]+, compounds 4 and 5) were missing in the
AN2545.3 deletant (Figure 1B). A search of known A. nidulans
secondary metabolites from CrossFire Beilstein database re-528 Chemistry & Biology 15, 527–532, June 2008 ª2008 Elsevier Ltdvealed that these five compounds had not been previously de-
scribed in A. nidulans.
All five compounds were isolated from large-scale cultivation
of wild-type A. nidulans by purification, initially by flash chroma-
tography and then by preparative HPLC. Full one- and two-di-
mensional NMR analysis of compound 1 identified the productAll rights reserved
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Aspergillus Emericellamide Pathwayas emericellamide A (Figure 1C and Tables S3 and S4), a mixed
cyclic polyketide nonribosomal peptide (active against methicil-
lin-resistant Staphylococcus aureus) produced by a marine
Emericella species (Oh et al., 2007). (Emericella is the genus
designation generally used for species ofAspergilluswith a dem-
onstrated sexual cycle.) The four other compounds were, to our
knowledge, completely new emericellamides (Figure 1C), and
we solved their structures by a combination of one- and two-di-
mensional NMR analyses and by comparison to emericellamide
A (1). (For detailed structural elucidation, see the Supplemental
Data.) The MS fragmentation also supports the assigned struc-
tures (Figures S2 and S3). The intensities of dehydration frag-
ments in compounds 3 and 5 are stronger than compounds 2
and 4 (m/z = 295, 323, 408, 436, and 507 for 2 and 3; m/z =
323, 351, 436, 464, and 535 for 4 and 5). These fragmentation
data also support the assigned structures of the aliphatic side
chains, because compounds 3 and 5 have two carbonyl a-pro-
tons that increase the probability of H2O elimination to generate
a,b-unsaturated carbonyl fragments. Similarity in structures and
the single biosynthetic origin leads us to name compounds 2–5
emericellamides C–F (Figure 1C). In addition to emericellamide
A (1), a minor peak having the same MS/MS fragments (data
not shown) with emericellamide A (1) was also observed in the
Figure 2. Boundary of Emericellamide
Synthesis eas Cluster
(A) Organization of the emericellamide synthase
gene cluster in A. nidulans. Black open reading
frame (ORF), genes involved in emericellamide
biosynthesis; gray ORF, genes not involved in
the pathway.
(B) LC-MS analysis of A. nidulansmutant metabo-
lites in positive ionmode, EIC atm/z 596, emericel-
lamides C and D [M+H]+; EIC at m/z 610, emericel-
lamide A [M+H]+; EIC at m/z 624, emericellamides
E and F [M+H]+.
EIC of 610 (Figure 1B). Although not pres-
ent in sufficient quantity to allow full NMR
characterization, this compound could
be another long-chained emericellamide
that did not undergo methyltransfer.
In fungi, biosynthesis genes of second-
ary metabolites are generally clustered.
To identify genes in the emericellamide
biosynthesis pathway, additional genes
surrounding the NRPS (from AN2542.3
to AN10325.3; Figure 2A) were deleted
and the mutant strains analyzed (Fig-
ure 2B and data not shown). The data
show that, using the BLAST NCBI protein
database, AN2547.3 (a type I PKS homo-
log), AN2548.3 (an acyltransferase homo-
log) and AN2549.3 (an AMP-dependent
CoA-ligase homolog) are involved in the
emericellamide biosynthetic pathway.
Though the structures of emericellamides
clearly suggest the involvement of a PKS,
the involvement of the two additional
genes provides evidence that the transfer of the polyketide inter-
mediates (i.e., the acyl side chains) from the PKS to the first thi-
olation domain of the NRPS is mediated by additional enzymes.
Our data show that deletants of AN2544.3 (a sugar transporter
homolog) and AN2546.3 (a hypothetical protein) continue to pro-
duce emericellamides.
The biosynthetic pathway of emericellamides can be deduced
by analyzing the four genes in the gene cluster, which we desig-
nate the eas (emericellamide synthesis) cluster. The biosynthesis
of emericellamide initiates from the highly reducing iterative type
I polyketide synthase EasB (AN2547.3; Figure 3). The enzyme
contains the ketosynthase (KS), acyl transferase (AT), methyl-
transferase (MT), dehydrogenase (DH), enoylreductase (ER), ke-
toreductase (KR), and acyl carrier protein (ACP) domains. The
single-module fungal polyketide iteratively catalyzes the forma-
tion of the linear polyketide chain. Isolation and identification of
emericellamide derivatives differing in the polyketide chain
length and degree of methylation provide evidence that EasB
produces several polyketides that can be further processed by
the downstream enzymes. The polyketide intermediate is not
transferred directly to the NRPS EasA (AN2545.3) but instead
is mediated by two additional enzymes as supported by our
genetic data. The polyketide is released from EasB as a linearChemistry & Biology 15, 527–532, June 2008 ª2008 Elsevier Ltd All rights reserved 529
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Aspergillus Emericellamide PathwayFigure 3. Model for Emericellamide A (1) Biosynthesispolyketide carboxylic acid, which is converted to a CoA thioester
by the acyl-CoA ligase EasD (AN2549.3). The substrate is then
loaded onto the acyltransferase EasC (AN2548.3), which shuttles
the polyketide intermediate to the first thiolation (T) domain of the
NRPS EasA (AN2545.3). Examples of transferase-mediated
transfer between carrier protein domains have recently been
characterized in the coronamic acid biosynthesis pathway (Stri-
eter et al., 2007). The NRPS EasA is a multimodular enzymatic
assembly that contains 18 domains grouped into five modules
corresponding to each of the five amino acidmonomers incorpo-
rated. The second to the fifth modules contain the three core
domains, the condensation (C) domain responsible for catalyz-
ing peptide bond formation, adenylation (A) domain responsible
for selecting the amino acid monomer substrate, and the thiola-
tion (T) domain. The first module in the NRPS contains a unique
T-E-C-A-T-E structure where (E) domains are epimerization do-
mains. We propose that the first of the two thiolation domains is
responsible for accepting the incoming polyketide from the acyl-
transferase EasC. The second thiolation domain is responsible
for accepting the glycine amino acid adenylated by the A domain
in the module. The condensation domain then catalyzes the C–N
bond formation between the upstream acyl thioester and the
downstream aminoacyl thioester. The roles of the two epimeriza-
tion domains located in the first module of the NRPS are unclear
as glycine is the amino acid activated by the module. The NRPS
does not contain a TE domain at the end of module 5, presum-
ably suggesting that TE is not necessary for the cyclization of
the emericellamides. Of the NRPS in the A. nidulans genome,
only ACV NRPS (AN2621.3), terrequinone NRPS (AN8513.3),
and the unannotated NRPS AN3396.3 contain a TE domain as
part of the enzyme. The nine residues that define the signature
sequence of A domain selectivity were identified and analyzed
using two publicly available bioinformatic software programs
(Table 1; Rausch et al., 2005; Yadav et al., 2003). Both software
tools, Search NRPS/PKS and NRPSpredictor, correctly pre-
dicted that the first module codes for glycine. However, the
specificity of the A domain in the second module was only cor-530 Chemistry & Biology 15, 527–532, June 2008 ª2008 Elsevier Ltrectly predicted by NRPSpredictor to be valine. The A domain
selectivity of the last three modules was predicted incorrectly
by both programs. Many characterized NRPS used by these
bioinformatic software tools are bacterial in origin, and under-
standing of fungal NRPS is still in its infancy. Identification of
the products of fungal NRPS from genome sequencing could
help in the development of a better understanding of the fungal
NRPS code.
SIGNIFICANCE
The rapid completion of fungal genome sequencing pro-
vides an unprecedented opportunity to study fungal second-
ary metabolism pathways. In this communication, we report
the application of gene-targeting approaches to functionally
characterize a pathway containing both a PKS and an NRPS
working to produce the cyclic polyketide peptide emericel-
lamides. Previously emericellamide A was only discovered
in a marine Emericella and produced in very small amounts
when the fungus was cultured alone. When the marine fun-
guswas stimulated by coculturingwith a bacterium, produc-
tion of emericellamide A was increased 100-fold (Oh et al.,
2007). By comparison, A. nidulans is a well-studied, estab-
lished laboratory model fungus, and the emericellamides
are produced by the A. nidulans cultured alone in levels
comparable to the bacterium stimulated marine fungus.
Table 1. Signature Sequences of the Adenylation (A) Domains
Amino Acid Module
Signature Sequence Position
235 236 239 278 299 301 322 330 331
Gly 1 D I Q G V L A M Q
Val 2 D A S Q I G G I Y
Leu 3 D I H F V G A I A
Ala 4 D L L V V A G I L
Ala 5 D I A I L V A I Ld All rights reserved
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Aspergillus Emericellamide PathwayOur efficient gene deletion approach allows rapid annota-
tion of the genes in A. nidulans and can be applied to other
secondary metabolite clusters. Replacement of the native
promoter with either inducible or strong constitutive
promoters is feasible and can provide a rational route to in-
crease the production of emericellamides. The identification
of the emericellamide pathway opens the door to the engi-
neering of the PKS and NRPS for the production of novel an-
alogs. Finally, additional functional annotation in A. nidulans
and other fungi will improve both our understanding of fun-
gal secondary metabolite biosynthesis and bioinformatic
analysis of fungal NRPS and PKS.
EXPERIMENTAL PROCEDURES
Molecular Genetic Procedures
Construction of fusion PCR products, protoplast production, and transforma-
tion were carried out as described (Szewczyk et al., 2006). For construction of
the fusion PCR fragments, two 1000 base-pair fragments upstream and
downstream of the targeted gene were amplified from genomic A. nidulans
DNA by PCR. Fusion PCR was set up with the two amplified flanking se-
quences and theA. fumigatus pyrG selectablemarker cassette. The three frag-
ments were fused into a singlemolecule and amplifiedwith two nested primers
(Figure S1 and Table S2). The DnkuA strain TN02A3 (Nayak et al., 2006) was
used as a recipient strain. Diagnostic PCR of deletant strains was performed
using the external primers used in the first round of the PCR. The difference
in the size between the gene replaced by the selective marker and the native
gene allowed the determination of correct gene replacement. In cases when
the sizes of both the wild-type and deletant products were similar, diagnostic
PCR was performed using one of the external primers and a primer located in-
side the marker gene. In those cases, the deletant gave the PCR product of the
expected size versus no product in the wild-type strain.
Fermentation and Purification
Spores of A. nidulans wild-type R153 and deletion strains were inoculated
(1 3 106/ml) into 100 ml glucose minimal medium (6 g/l NaNO3, 0.52 g/l KCl,
0.52 g/l MgSO4 7H2O, 1.52 g/l KH2PO4, 10 g/l D-glucose, 1 ml/l trace element
solution [Cove, 1966]) supplemented with pyridoxine (0.5 mg/ml) and cultivated
at 37Cwith shaking at 250 rpm. After 4 days, culturemediumwas collected by
filtration and extracted with the same volume of EtOAc two times. The com-
bined EtOAc layer was evaporated in vacuo and redissolved in MeOH
(1 mg/ml) for HPLC-DAD-MS analysis. For structure elucidation, a 10-liter
fermentation volume was extracted with EtOAc to yield a gray powder
(350 mg), which was applied to a Si gel column (Merck 230–400 mesh,
ASTM, 103 100mm) and eluted with CHCl3-MeOHmixtures of increasing po-
larity (fraction A, 1:0, 300 ml; fraction B, 19:1, 300 ml; fraction C, 9:1, 300 ml;
fraction D, 7:3, 300 ml). The solvent of fraction B, containing emericellamides,
was evaporated in vacuo and resuspended in CHCl3. The emericellamides,
which do not dissolve in CHCl3, were collected by filtration. Enriched emericel-
lamides were separated by preparative HPLC (Phenomenex Luna 5 mm C18
[2], 2503 21.2 mm) with a flow rate of 10.0 ml/min and measured by a UV de-
tector at 200 nm. The gradient systemwasMeCN (solvent B) in 5%MeCN/H2O
(solvent A): 60% to 100% B from 0 to 15 min, 100% B from 15 to 20 min, and
re-equilibration with 60% B from 20 to 22 min. A mixture of emericellamides
C and D (6.6 mg), emericellamide A (1.2 mg), and a mixture of emericellamides
E and F (5.6 mg) were eluted at 11.4, 12.5, and 14.8 min, respectively. Emer-
icellamides C (2.8 mg, tR = 36.2 min) and D (2.5 mg, tR = 37.8 min) were further
purified by the same HPLC using isocratic 50% B solvent. Emericellamides
E (1.4 mg, tR = 47.0 min) and F (2.6 mg, tR = 49.1 min) were further purified
by the same HPLC using isocratic 55% B solvent.
SUPPLEMENTAL DATA
Supplemental Data include detailed structural characterization of emericella-
mides, A. nidulans strains and primers used in this study, fusion PCR for
gene disruption, 1H and 13C NMR spectral data, and MS/MS fragmentationChemistry & Biologyof emericellamides, and are available with this article online at http://www.
chembiol.com/cgi/content/full/15/6/527/DC1/.
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